SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-15-198748
Filing Date
2015-05-22
Accepted
2015-05-22 16:25:49
Documents
2
Group Members
AMIR NASHATJONATHAN A. FLINTPOLARIS VENTURE MANAGEMENT CO. V, L.L.C.POLARIS VENTURE PARTNERS ENTREPRENEURS FUND V, L.P.POLARIS VENTURE PARTNERS FOUNDERS FUND V, L.P.POLARIS VENTURE PARTNERS SPECIAL FOUNDERS FUND V, L.P.TERRANCE G. MCGUIRE

Document Format Files

Seq Description Document Type Size
1 SC 13DA d930146dsc13d.htm SC 13D 144357
2 EX-A d930146dex99a.htm EX-99.A 10863
  Complete submission text file 0001193125-15-198748.txt   157065
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Subject) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE
Type: SC 13D | Act: 34 | File No.: 005-88839 | Film No.: 15886925
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1000 WINTER STREET SUITE 3350 WALTHAM MA 02451
Business Address 1000 WINTER STREET SUITE 3350 WALTHAM MA 02451 781-290-0770
Polaris Venture Partners V, L.P. (Filed by) CIK: 0001439590 (see all company filings)

IRS No.: 204234825 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D